Inventor · disambiguated record
Wataru Hirose
Also filed as: HIROSE WATARU
10 granted patents·3 pending applications·23 citations·filing 2015–2025
85Inventor score
Files withSUMITOMO PHARMA CO LTD6SUMITOMO DAINIPPON PHARMA CO LTD4BOSTON BIOMEDICAL INC2SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1
Top patents by PatentIndex Score
13 records- 0191US11279694B2Alvocidib prodrugs and their use as protein kinase inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2017·Granted Mar 22, 2022·6 cites·4 claims
- 0291US10815241B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 27, 2020·4 cites·10 claims
- 0390US11564920B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jan 31, 2023·2 cites·18 claims
- 0489US11911381B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·15 claims
- 0585US11369605B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Jun 28, 2022·5 cites·39 claims
- 0683US11325921B2Optically active crosslinked cyclic secondary amine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted May 10, 2022·2 cites·23 claims
- 0781US12263167B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Granted Apr 1, 2025·0 cites·19 claims
- 0878US10017488B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2015·Granted Jul 10, 2018·2 cites·17 claims
- 0976US10683274B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2018·Granted Jun 16, 2020·1 cites·1 claims
- 1072US2025177395A1Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1164US12410154B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Sep 9, 2025·0 cites·70 claims
- 1260US2025129049A11h-pyrazole-3-amine derivative having bicyclic backboneSUMITOMO PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1343US2021198283A1Optically active bridged piperidine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wataru Hirose files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →